KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity: 2013-2025

Historic Return on Equity for Sarepta Therapeutics (SRPT) over the last 11 years, with Jun 2025 value amounting to -0.20%.

  • Sarepta Therapeutics' Return on Equity fell 25.00% to -0.20% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.20%, marking a year-over-year decrease of 25.00%. This contributed to the annual value of 0.20% for FY2024, which is 106.00% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Return on Equity of -0.20% as of Q2 2025, which was down 216.36% from 0.17% recorded in Q4 2024.
  • Sarepta Therapeutics' 5-year Return on Equity high stood at 0.17% for Q4 2024, and its period low was -2.03% during Q1 2023.
  • Over the past 3 years, Sarepta Therapeutics' median Return on Equity value was -0.20% (recorded in 2025), while the average stood at -0.52%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 163bps in 2023, then spiked by 205bps in 2024.
  • Sarepta Therapeutics' Return on Equity (Quarterly) stood at -0.60% in 2021, then crashed by 113bps to -1.73% in 2022, then soared by 107bps to -0.66% in 2023, then surged by 83bps to 0.17% in 2024, then declined by 25bps to -0.20% in 2025.
  • Its Return on Equity stands at -0.20% for Q2 2025, versus 0.17% for Q4 2024 and 0.11% for Q3 2024.